Allosteric Interactions between the Myristate- and ATP-Site of the Abl Kinase
Published 2011 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Allosteric Interactions between the Myristate- and ATP-Site of the Abl Kinase
Authors
Keywords
-
Journal
PLoS One
Volume 6, Issue 1, Pages e15929
Publisher
Public Library of Science (PLoS)
Online
2011-01-11
DOI
10.1371/journal.pone.0015929
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Discovery of a small-molecule type II inhibitor of wild-type and gatekeeper mutants of BCR-ABL, PDGFR , Kit, and Src kinases: novel type II inhibitor of gatekeeper mutants
- (2010) E. Weisberg et al. BLOOD
- MK-2206, an Allosteric Akt Inhibitor, Enhances Antitumor Efficacy by Standard Chemotherapeutic Agents or Molecular Targeted Drugs In vitro and In vivo
- (2010) H. Hirai et al. MOLECULAR CANCER THERAPEUTICS
- Targeting Bcr–Abl by combining allosteric with ATP-binding-site inhibitors
- (2010) Jianming Zhang et al. NATURE
- AP24534, a Pan-BCR-ABL Inhibitor for Chronic Myeloid Leukemia, Potently Inhibits the T315I Mutant and Overcomes Mutation-Based Resistance
- (2009) Thomas O'Hare et al. CANCER CELL
- Equally Potent Inhibition of c-Src and Abl by Compounds that Recognize Inactive Kinase Conformations
- (2009) M. A. Seeliger et al. CANCER RESEARCH
- N-Myristoylated c-Abl Tyrosine Kinase Localizes to the Endoplasmic Reticulum upon Binding to an Allosteric Inhibitor
- (2009) Yongmun Choi et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- 9-(Arenethenyl)purines as Dual Src/Abl Kinase Inhibitors Targeting the Inactive Conformation: Design, Synthesis, and Biological Evaluation
- (2009) Wei-Sheng Huang et al. JOURNAL OF MEDICINAL CHEMISTRY
- Factors underlying sensitivity of cancers to small-molecule kinase inhibitors
- (2009) Pasi A. Jänne et al. NATURE REVIEWS DRUG DISCOVERY
- Conformational disturbance in Abl kinase upon mutation and deregulation
- (2009) R. E. Iacob et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- High-Speed and High-Resolution UPLC Separation at Zero Degrees Celsius
- (2008) Thomas E. Wales et al. ANALYTICAL CHEMISTRY
- Inhibitors of ABL and the ABL-T315I Mutation
- (2008) Glenn Noronha et al. CURRENT TOPICS IN MEDICINAL CHEMISTRY
- Solution Conformations and Dynamics of ABL Kinase-Inhibitor Complexes Determined by NMR Substantiate the Different Binding Modes of Imatinib/Nilotinib and Dasatinib
- (2008) Navratna Vajpai et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Activation of tyrosine kinases by mutation of the gatekeeper threonine
- (2008) Mohammad Azam et al. NATURE STRUCTURAL & MOLECULAR BIOLOGY
- SGX393 inhibits the CML mutant Bcr-AblT315I and preempts in vitro resistance when combined with nilotinib or dasatinib
- (2008) T. O'Hare et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreDiscover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversation